In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Northern Light Pharmaceuticals AB

www.nlpab.com

Latest From Northern Light Pharmaceuticals AB

Biopharma In Sweden: A Comfortable Climate For Start-Ups

Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.

BioPharmaceutical Sweden

Start-Up Previews, July-August 2014

This Month's Profile Groups: Biopharma In Sweden, features profiles of Northern Light Pharmaceuticals, Sigrid Therapeutics, and Swecure; ENT Devices features profiles of Aerin Medical, ENTvantage Diagnostics, Fiagon, and Spirox. Plus these Start-Ups Across Health Care: Anagnostics Bioanalysis, Check-Cap, Edico Genome, G1 Therapeutics, HeadSense Medical, Innovent Biologics, Navitor Pharmaceuticals, Onciomed, and RevMedx.

BioPharmaceutical Medical Device

Northern Light Pharmaceuticals AB

Swedish start-up Northern Light Pharmaceuticals AB spun out of AstraZeneca AB with a portfolio of early-stage products designed to meet the aging population’s unmet needs in treating cancer, inflammatory pain, and neurological disorders.

BioPharmaceutical

Biopharma In Sweden: A Comfortable Climate For Start-Ups

Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups. Profiles of Northern Light Pharmaceuticals AB, Sigrid Therapeutics, and Swecure AB.

BioPharmaceutical Sweden
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Northern Light Pharmaceuticals AB
  • Senior Management
  • Achim Orzechowski, CEO
    Stefan Berg, EVP, R&D
  • Contact Info
  • Northern Light Pharmaceuticals AB
    Phone: (0) 703 111 685
    Forskargatan 20J, B215
    Södertälje, 151 36
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register